Polidocanol | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Polidocanol
US Patents

PharmaCompass Sponsored Ads

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

With Fermion, start the journey of your innovative API.

Contact Supplier

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Polidocanol

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

3 API Suppliers, 1 USDMF, 2 Listed Suppliers, $ API Reference Price

3 API Suppliers
1 USDMF
2 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

6 FDF Dossiers, 4 FDA Orange Book, 2 Listed Dossiers

6 FDF Dossiers
4 FDA Orange Book
2 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - 180MG/18ML (10MG/ML), SOLUTION;INTRAVENOUS - 77.5MG/7.75ML (10MG/ML), SOLUTION;INTRAVENOUS - 10MG/2ML (5MG/ML), SOLUTION;INTRAVENOUS - 20MG/2ML (10MG/ML)

SOLUTION;INTRAVENOUS - 180MG/18ML (10MG/ML)
SOLUTION;INTRAVENOUS - 77.5MG/7.75ML (10MG/ML)
SOLUTION;INTRAVENOUS - 10MG/2ML (5MG/ML)
SOLUTION;INTRAVENOUS - 20MG/2ML (10MG/ML)

RELATED EXCIPIENT COMPANIES

1 Actylis, 1 Finar

1 Actylis
1 Finar

EXCIPIENTS BY APPLICATIONS

1 Parenteral, 1 Topical

1 Parenteral
1 Topical

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 2 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
2 NEWS #PharmaBuzz

MARKET PLACE

3 APIs

3 APIs

PATENTS & EXCLUSIVITIES

4 US Patents, 2 Health Canada Patents

4 US Patents
2 Health Canada Patents

$ API Ref.Price (USD/KG) : 49 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

4 All

01 4PROVENSIS

filter Patent Number Reset all filters

4 All

01 17731986

02 17814943

03 18122917

04 19480652

filter API Patent Reset all filters

4 All

01 1Y

02 3Blank

filter FDF Patent Reset all filters

4 All

01 4Y

filter Expiration Date Reset all filters

4 All

01 12024-09-09

02 12024-11-17

03 12027-11-19

04 12032-05-12

LGM Polidocanol

Product Main Page

01

PROVENSIS

Antibody Engineering

Not Confirmed

PROVENSIS

United Kingdom

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-11-17

POLIDOCANOL

US Patent Number : 7731986

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 205098

Patent Use Code : U-1463

Delist Requested :

Patent Use Description : A METHOD OF INTRAVENOU...

Patent Expiration Date : 2024-11-17

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

02

PROVENSIS

Antibody Engineering

Not Confirmed

PROVENSIS

United Kingdom

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-11-19

POLIDOCANOL

US Patent Number : 7814943

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 205098

Patent Use Code : U-1461

Delist Requested :

Patent Use Description : A METHOD OF GENERATING...

Patent Expiration Date : 2027-11-19

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

03

PROVENSIS

Antibody Engineering

Not Confirmed

PROVENSIS

United Kingdom

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-09-09

POLIDOCANOL

US Patent Number : 8122917

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 205098

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-09-09

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

04

PROVENSIS

Antibody Engineering

Not Confirmed

PROVENSIS

United Kingdom

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-05-12

POLIDOCANOL

US Patent Number : 9480652

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 205098

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-05-12

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?